Group 1 - The investor compensation case for Huatie Co., Ltd. has concluded with a victory for shareholders, requiring the company to compensate investors for their losses as calculated [1][2] - Investors who purchased shares between April 26, 2019, and April 28, 2023, and sold or still hold shares at a loss after April 29, 2023, are eligible to register for compensation [3] - The likelihood of success for similar cases is high due to the precedent set by the final ruling, encouraging affected investors to actively participate in the compensation process [3] Group 2 - The company received an administrative penalty decision from the China Securities Regulatory Commission on May 15, 2024, confirming violations in its annual reports for 2020 and 2021, including false statements and undisclosed related transactions [3] - Even after delisting, investors retain the right to claim compensation for losses incurred due to the company's fraudulent activities, as delisting does not exempt the company from legal responsibilities [2][3] - The statute of limitations for filing claims will expire on April 28, 2026, urging eligible investors to register promptly to avoid missing the opportunity for compensation [2][3]

Core Viewpoint - The article discusses the legal proceedings against Guangji Pharmaceutical due to financial reporting irregularities, highlighting the potential for investor compensation through a class action lawsuit [1][2][3]. Group 1: Legal Proceedings - A new batch of cases has been submitted to the court by the Liu Peng lawyer team from Shanghai Huzhi Law Firm, currently seeking affected investors [1][2]. - The case was initiated after Guangji Pharmaceutical received an administrative penalty decision from the Hubei regulatory authority on July 22, indicating issues with the company's financial reports [1][2]. Group 2: Financial Reporting Irregularities - Guangji Pharmaceutical's subsidiary, Hubei Guangji Pharmaceutical Jikang, reported inflated revenues by using the gross method instead of the net method for revenue recognition, leading to overstatements of 45.60 million yuan, 136.86 million yuan, and 138.20 million yuan for the first, half, and third quarters of 2022, respectively, which accounted for 25.49%, 26.68%, and 20.49% of the reported revenues for those periods [3]. - The company issued a correction announcement in April 2023, acknowledging the accounting errors for the first three quarters of 2022, which were deemed violations of the Securities Law of the People's Republic of China [2][3].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、已有终审胜诉判决 上海沪紫律师事务所刘鹏律师代理的索赔案近日收到一批胜诉判决，目前仍在陆续递交立案中。（刘鹏 律师专栏） 回溯此案，2025年8月，湖北省高级人民法院对农尚环境（维权）证券虚假陈述责任纠纷案作出终审胜 诉判决。这一判决结果源自农尚环境未及时披露2023年度业绩预告及退市风险警示的违规行为2。基于 已生效的判决，凡在特定期间内投资农尚环境股票并遭受损失的投资者，现在均可依法参与索赔。 提示依据判决，于2024年1月31日-2024年4月28日期间买入，并在2024年4月29日之后卖出或仍持有而亏 损的仍有机会加入索赔，挽回损失。对于符合索赔条件的投资者而言，及时采取行动是挽回损失的关 键。（农尚环境维权入口） 二、未及时履行信披义务 为何被投资者起诉牵涉到公司此前收到的一则警示函。 案情回溯，2024年11月5日，农尚环境发布《关于收到湖北证监局警示函的公告》，公告显示，经查， ...

Group 1 - The core issue revolves around regulatory penalties faced by Aolian Electronics due to false statements made in a cross-industry cooperation announcement related to perovskite investment [1] - Aolian Electronics announced a partnership on December 9, 2022, but subsequent clarifications revealed discrepancies in the claims made about the partner's qualifications, leading to a significant drop in the company's stock price [1] - Following the regulatory decision, numerous affected investors have initiated lawsuits against Aolian Electronics, seeking compensation for their losses incurred due to the misleading information [1] Group 2 - Investors who purchased shares between December 9, 2022, and February 20, 2023, and either sold or still hold shares at a loss after February 21, 2023, are eligible to participate in the legal action [2] - The statute of limitations for the case is set to expire on February 20, 2026, urging eligible investors to act quickly to recover their losses [2] - The lawyer representing the investors has a strong track record, having successfully represented over 300 companies and handled more than 14,000 cases, with a high win rate [2]

Core Viewpoint - The company is facing significant legal challenges due to violations in information disclosure, leading to a high probability of compensation for affected investors [1][5]. Group 1: Legal Proceedings - A total of 754 investor compensation claims have been filed against the company, involving approximately 69.25 million yuan [5]. - The claims stem from an administrative penalty received on November 28, 2024, due to violations in information disclosure [5]. - The main violations include false records in the annual reports for 2017 and 2019, resulting in fines exceeding 10 million yuan for the company and severe penalties for responsible individuals [3][5]. Group 2: Investor Eligibility for Compensation - Two categories of investors are eligible to join the compensation efforts: 1. Investors who purchased shares between April 15, 2021, and April 29, 2024, and sold or still hold them after April 30, 2024, at a loss [2]. 2. Investors who bought shares between April 24, 2018, and May 30, 2024, and sold or still hold them after May 31, 2024, at a loss [2]. Group 3: Financial Misconduct Details - The company’s financial misconduct dates back to a 2015 acquisition of a 70% stake in another company, which was included in the consolidated financial statements [3][6]. - Between October 17 and December 4, 2017, the subsidiary signed six procurement contracts totaling 21.774 million yuan for storage devices, and sales contracts with another company amounting to 26.4814 million yuan [3][6]. - The goods involved in these contracts were never delivered, leading to the false records in the 2017 and 2019 annual reports [6]. Group 4: Company’s Future Steps - The company has announced its application to revoke other risk warnings, indicating a potential new phase for the company [6]. - Affected investors are encouraged to actively participate in the compensation process to recover their losses [6].

Group 1 - Some investors have already received compensation through legal actions against the company, with ongoing recruitment for additional claims [1][3] - The company, Xilong Science, faced a civil lawsuit regarding "securities false statement liability" with a court ruling in favor of 82 individual investors, leading to the company withdrawing its appeal [1][3] - The compensation claims stem from an administrative penalty received by the company in July 2023 for inflating revenue through fictitious trade activities [1][3] Group 2 - The China Securities Regulatory Commission (CSRC) discovered significant financial fraud by the company, with a total of over 2.8 billion yuan in inflated revenue from 2020 to mid-2022 [2][4] - Specifically, the company inflated revenue by 598 million yuan in 2020, 1.458 billion yuan in 2021, and 785 million yuan in the first half of 2022 [2][4] - In 2021, the inflated revenue accounted for 21.32% of the total revenue, while the inflated profit represented 5.93% of the total profit [2][4] - Following the principle of "same case, same judgment," similar cases are expected to receive quicker rulings, increasing the likelihood of winning for affected investors [2][4]

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、已有案件递交立案 *ST恒久（维权）曾收到江苏证监局的《行政处罚决定书》，因财务造假被处以800万元罚款。 上海沪紫律师事务所刘鹏律师代理的投资者诉*ST恒久证券虚假陈述案已陆续提交至该公司管辖地法院 立案审理。目前维权仍可加入，公告中提到，公司存在财报造假行为。（刘鹏律师专栏） 至此，对于2020年4月22日-2023年11月9日期间买入，并在2023年11月10日之后卖出或仍持有而亏 损的投资者及时参与索赔是挽回损失的途径。（ST恒久维权入口） 法院在收到案件后，将依法进行审理，并保障投资者的合法权益。同时，这也提醒广大投资者，在投资 过程中要密切关注公司的财务状况和经营情况，以避免类似的风险。 （本文由上海沪紫律师事务所刘鹏律师供稿，不代表新浪财经的观点。刘鹏律师，专注证券维权19年， 自2006年执业以来，成功为中青宝、国华网安、劲嘉股份（维权）等 300 余家上市公司的中小投资者成 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、已有案件递交立案 7月18日，诺泰生物披露收到证监会下发的《行政处罚事先告知书》，并且监管查明公司存在严重的财 务造假行为。 上海沪紫律师事务所刘鹏律师代理的案件也已陆续递交立案，等待法院审理中。根据公司业绩来看，营 收净利均增长。其前三季度实现营业收入15.27亿元，同比增长21.95%；归属净利润4.45亿元，同比增 长26.92%。（刘鹏律师专栏） 上市公司信息披露违法违规行为不仅严重扰乱证券市场秩序，更是对股民合法权益的严重侵害。根据相 关法律法规，受损投资者可提起诉讼，要求上市公司赔付损失。 索赔条件为于2022年4月28日-2024年10月23日（含当日）之前买入，并在2024年10月24日之后卖出或仍 持有而亏损的还可加入。（诺泰生物维权入口） 二、财报造假被重罚 据事先告知书，该公司2021年年报存在虚假记载，虚增营业收入300 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 一、立案调查进行中 12月5日晚间，科净源（维权）发布公告称，公司同意续聘大信会计师事务所（特殊普通合伙）为公司 2025年度财务及内控审计机构。 目前，公司还需面临投资者索赔事宜，10月10日，科净源公告收到中国证监会北京监管局下发的《行政 处罚决定书》。 上海沪紫律师事务所刘鹏律师代理的科净源索赔案，近日律师团队已递交一批次案件至公司管辖地法院 立案。目前，符合于2023年10月26日-2024年4月29日期间买入，并在2024年4月30日之后卖出或仍持有 而亏损的还可参与维权。（科净源维权入口） 二、违规担保被处罚 经查明，科净源存在以下违法事实：2023年12月至2024年1月，公司全资子公司安装公司为三家公司以 定期存单质押方式提供担保。 这些担保均未履行科净源董事会、股东大会审议程序，属于应当及时披露的重大事件，但科净源未按规 定及时披 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 持有这两只股票的受损投资者在收到损失测算报告后，等待他们的不再是漫长的诉讼，而是一个高概率 获赔的结果。（刘鹏律师专栏） 一、证券维权领域再获胜诉 本周，证券维权领域取得了实质性突破。 深圳中级人民法院就投资者诉ST英飞拓（维权）证券虚假陈述案作出判决，宣告投资者一审胜诉。 上海沪紫律师事务所刘鹏律师团队代理的数百个案件也同步收到核损报告。 与此同时，南宁市中级人民法院对ST智知（维权）（新智认知）索赔案件也作出了一审胜诉判决。因 ST智知方面已提起上诉，案件目前已进入二审程序。 尽管一审判决尚未生效，但刘鹏律师指出此类案件二审改判的几率不大。 两家公司分别因不同年度的财务报告存在虚假记载而遭到监管部门的调查与处罚，引发了投资者的广泛 维权行动。 二、具体违规事实 据监管调查，英飞拓的问题主要集中在2019年至2020年的财务数据。 深圳证监局查明 ...